Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $16,876 | 1,061 | 99.1% |
| Education | $157.14 | 5 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $4,519 | 328 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $2,620 | 156 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $1,429 | 78 | $0 (2024) |
| Janssen Biotech, Inc. | $1,046 | 67 | $0 (2024) |
| QOL Medical, LLC | $853.23 | 37 | $0 (2024) |
| PFIZER INC. | $663.20 | 43 | $0 (2024) |
| Merck Sharp & Dohme LLC | $600.41 | 38 | $0 (2024) |
| Gilead Sciences, Inc. | $494.97 | 30 | $0 (2024) |
| Ferring Pharmaceuticals Inc. | $407.81 | 28 | $0 (2024) |
| IRONWOOD PHARMACEUTICALS, INC | $358.35 | 22 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,792 | 165 | ABBVIE INC. ($877.23) |
| 2023 | $2,640 | 153 | ABBVIE INC. ($722.60) |
| 2022 | $2,270 | 132 | ABBVIE INC. ($735.02) |
| 2021 | $2,879 | 182 | AbbVie Inc. ($748.55) |
| 2020 | $1,727 | 120 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($470.85) |
| 2019 | $1,702 | 118 | AbbVie, Inc. ($462.68) |
| 2018 | $1,633 | 106 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($357.97) |
| 2017 | $1,389 | 90 | Valeant Pharmaceuticals North America LLC ($225.53) |
All Payment Transactions
1,066 individual payment records from CMS Open Payments — Page 1 of 43
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $15.22 | General |
| Category: Immunology | ||||||
| 12/17/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $17.87 | General |
| Category: Immunology | ||||||
| 12/16/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $20.27 | General |
| 12/15/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $4.27 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/11/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $22.45 | General |
| Category: THERAPY FOR CSID | ||||||
| 12/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.59 | General |
| Category: Gastroenterology | ||||||
| 12/11/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $16.85 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $4.60 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/09/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug) | Food and Beverage | In-kind items and services | $19.64 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 12/06/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $18.65 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/05/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $18.55 | General |
| Category: LIVER DISEASE | ||||||
| 12/04/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $17.37 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $2.74 | General |
| Category: THERAPY FOR CSID | ||||||
| 12/02/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $15.92 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/26/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $11.75 | General |
| Category: Gastroenterology | ||||||
| 11/25/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $25.47 | General |
| Category: IMMUNOLOGY | ||||||
| 11/22/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $18.87 | General |
| Category: VIROLOGY | ||||||
| 11/21/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $39.50 | General |
| Category: Immunology | ||||||
| 11/19/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $15.69 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $1.33 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/14/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $34.23 | General |
| Category: THERAPY FOR CSID | ||||||
| 11/13/2024 | Braintree Laboratories, Inc. | SUFLAVE (Drug), SUTAB | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: GI COLON PREP | ||||||
| 11/12/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.51 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/11/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $21.69 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/06/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 1,020 | 1,053 | $461,645 | $104,928 |
| 2022 | 13 | 898 | 936 | $406,900 | $92,083 |
| 2021 | 14 | 970 | 1,044 | $445,130 | $101,771 |
| 2020 | 13 | 905 | 976 | $379,480 | $88,529 |
All Medicare Procedures & Services
55 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 88 | 90 | $90,000 | $17,168 | 19.1% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 72 | 72 | $57,600 | $12,468 | 21.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 128 | 143 | $18,750 | $11,994 | 64.0% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 138 | 144 | $79,200 | $10,802 | 13.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 111 | 111 | $16,690 | $8,287 | 49.7% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 65 | 66 | $59,400 | $7,389 | 12.4% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 35 | 35 | $28,000 | $6,134 | 21.9% |
| 91110 | Imaging of digestive tract done from the inside of the digestive tract | Office | 2023 | 11 | 11 | $19,800 | $6,112 | 30.9% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 135 | 135 | $16,210 | $5,945 | 36.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 49 | 49 | $8,945 | $5,071 | 56.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 63 | 68 | $6,655 | $4,258 | 64.0% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 32 | 32 | $25,600 | $4,095 | 16.0% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 28 | 29 | $14,500 | $2,090 | 14.4% |
| 43450 | Dilation of esophagus | Facility | 2023 | 53 | 55 | $11,000 | $1,669 | 15.2% |
| 43248 | Insertion of guide wire with dilation of esophagus using a flexible endoscope | Facility | 2023 | 12 | 13 | $9,295 | $1,447 | 15.6% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 99 | 101 | $101,000 | $19,560 | 19.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 124 | 150 | $18,750 | $12,535 | 66.9% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 66 | 66 | $52,800 | $11,590 | 22.0% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 103 | 106 | $58,300 | $8,531 | 14.6% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 41 | 42 | $33,600 | $7,229 | 21.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 86 | 86 | $12,900 | $5,884 | 45.6% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 57 | 57 | $51,300 | $5,418 | 10.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 43 | 43 | $7,785 | $5,145 | 66.1% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 109 | 109 | $13,080 | $4,574 | 35.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 59 | 63 | $5,985 | $3,614 | 60.4% |
About Dr. Daniel Iseman, MD
Dr. Daniel Iseman, MD is a Gastroenterology healthcare provider based in Columbia, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1093777310.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Iseman, MD has received a total of $17,033 in payments from pharmaceutical and medical device companies, with $2,792 received in 2024. These payments were reported across 1,066 transactions from 43 companies. The most common payment nature is "Food and Beverage" ($16,876).
As a Medicare-enrolled provider, Iseman has provided services to 3,793 Medicare beneficiaries, totaling 4,009 services with total Medicare billing of $387,312. Data is available for 4 years (2020–2023), covering 55 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Location Columbia, SC
- Active Since 04/03/2006
- Last Updated 03/11/2016
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1093777310
Products in Payments
- XIFAXAN (Drug) $2,128
- RINVOQ (Biological) $867.88
- STELARA (Biological) $865.82
- ENTYVIO (Biological) $761.20
- XELJANZ (Drug) $648.26
- HUMIRA (Biological) $617.95
- MAVYRET (Drug) $604.55
- DIFICID (Drug) $589.03
- Humira (Biological) $543.94
- TRULANCE (Drug) $493.15
- SUCRAID (Drug) $491.26
- LINZESS (Drug) $466.99
- Entyvio (Biological) $450.30
- DUPIXENT (Biological) $450.27
- SKYRIZI (Biological) $442.58
- CREON (Drug) $380.50
- Sucraid (Drug) $361.97
- IBSRELA (Drug) $357.19
- Linzess (Drug) $336.14
- ZEPOSIA (Drug) $317.25
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Columbia
Rudrajit Rai, Md, MD
Gastroenterology — Payments: $345,636
Dr. Joseph Meserve, M.d, M.D
Gastroenterology — Payments: $86,610
Kenneth Vega, Md, MD
Gastroenterology — Payments: $60,525
Bradley Anderson, Md, MD
Gastroenterology — Payments: $57,839
Dr. Robert Mcclure, Md, MD
Gastroenterology — Payments: $53,900
Dr. Michael Williams, Md, MD
Gastroenterology — Payments: $48,728